Drug intelligence / Profile preview

Umbilical cord mesenchymal stem cells (Chinese PLA General Hospital)

Development stage
Unknown
Lead developer
Chinese PLA General Hospital
Modality
Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

Umbilical cord mesenchymal stem cells (UC-MSCs) are an investigational cell therapy being developed by the Chinese PLA General Hospital for the treatment of severe, large-area burns and skin wound injuries. These multipotent cells are harvested from umbilical cord tissue and are utilized for their ability to promote tissue repair, reduce inflammation, and modulate the immune response through paracrine signaling and potential differentiation. In clinical applications for burns, these cells are transplanted onto the wound site to facilitate the regeneration of skin structures, such as sweat glands, and to accelerate the healing of extensive cutaneous lesions. The therapy aims to improve clinical outcomes and reduce scarring in patients with significant skin loss.

Other names
UC-MSCsUmbilical Cord Mesenchymal Stem CellsMSCs

Beyond the preview

Go deeper on Umbilical cord mesenchymal stem cells (Chinese PLA General Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Umbilical cord mesenchymal stem cells (Chinese PLA General Hospital).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call